Zevra Therapeutics
ZVRA
#7160
Rank
NZ$0.64 B
Marketcap
$11.95
Share price
-5.26%
Change (1 day)
45.47%
Change (1 year)

P/S ratio for Zevra Therapeutics (ZVRA)

P/S ratio as of April 2025 (TTM): 16.1

According to Zevra Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 9.60. At the end of 2024 the company had a P/S ratio of 19.0.

P/S ratio history for Zevra Therapeutics from 2023 to 2024

PS ratio at the end of each year

Year P/S ratio Change
202419.083.23%
202310.4